Literature DB >> 12189460

Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship?

G Espinosa1, J Font, F J Muñoz-Rodríguez, R Cervera, M Ingelmo.   

Abstract

A variety of systemic autoimmune disorders have been reported in patients with myelodysplastic and myeloproliferative syndromes. A possible association with polymyalgia rheumatica and giant cell arteritis has also been recognised. We report another case of polymyalgia rheumatica and one of giant cell arteritis associated with a myelodysplastic syndrome and the two first cases of giant cell arteritis associated with essential thrombocytaemia and chronic myelomonocytic leukaemia, respectively. It seems that there is a relationship between these entities, but the nature of this association is still unknown.

Entities:  

Mesh:

Year:  2002        PMID: 12189460     DOI: 10.1007/s100670200081

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  12 in total

1.  Concurrence of malignant fibrohistiocytoma and Takayasu arteritis: a case report.

Authors:  Jin-Feng Du; Jin-Wei Chen; Fen Li; Jing Tian; Xi Xie; Ni Mao
Journal:  Rheumatol Int       Date:  2011-10-04       Impact factor: 2.631

2.  The age-risk relationship of hematologic malignancies in patients with rheumatoid arthritis: a nationwide retrospective cohort study.

Authors:  Yu-Chih Lin; Hui-Wen Chou; Wen-Chan Tsai; Jeng-Hsien Yen; Shun-Jen Chang; Yi-Ching Lin
Journal:  Clin Rheumatol       Date:  2015-05-20       Impact factor: 2.980

3.  Temporal arteritis presenting with gastrointestinal symptoms in a middle aged man.

Authors:  Hasan S Jafri; Christopher Sofianos; Eyas M Hattab; Andrew J Overhiser; Michael Chiorean
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

4.  Polymyalgia rheumatica development in a patient under PI3K inhibitor therapy for chronic lymphocytic leukaemia.

Authors:  Sanah Sajawal; Sarah L Mackie; Peter Hillmen; Dennis McGonagle
Journal:  BMJ Case Rep       Date:  2017-11-08

Review 5.  Acute myeloid leukemia developing in patients with autoimmune diseases.

Authors:  Safaa M Ramadan; Tamer M Fouad; Valentina Summa; Syed Kh Hasan; Francesco Lo-Coco
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

Review 6.  [Hemato-oncological diseases. Associated rheumatic symptoms].

Authors:  M Reuss-Borst
Journal:  Z Rheumatol       Date:  2011-09       Impact factor: 1.372

7.  Malignancy risk in patients with giant cell arteritis: a population-based cohort study.

Authors:  Tanaz A Kermani; Valentin S Schäfer; Cynthia S Crowson; Gene G Hunder; Sherine E Gabriel; Steven R Ytterberg; Eric L Matteson; Kenneth J Warrington
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-02       Impact factor: 4.794

8.  MDS and GCA: a prognostic dilemma.

Authors:  Neha G Narula; Andy Abril
Journal:  Clin Rheumatol       Date:  2015-06-18       Impact factor: 2.980

Review 9.  Myelodysplastic syndromes and autoimmune diseases--case series and review of literature.

Authors:  Omar Al Ustwani; Laurie A Ford; Sheila J N Sait; Anne Marie W Block; Maurice Barcos; Carlos E Vigil; Elizabeth A Griffiths; James E Thompson; Eunice S Wang; Julian Ambrus; Meir Wetzler
Journal:  Leuk Res       Date:  2013-05-18       Impact factor: 3.156

10.  Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations.

Authors:  Panagiotis T Diamantopoulos; Maria Michael; Olga Benopoulou; Efthymia Bazanis; George Tzeletas; John Meletis; George Vayopoulos; Nora-Athina Viniou
Journal:  Virol J       Date:  2012-01-03       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.